Novartis (United Kingdom)

Novartis UK is the British subsidiary of the Swiss multinational pharmaceutical company, developing innovative medicines in oncology, immunology, neuroscience, cardiovascular disease, and ophthalmology. Key products include Entresto (sacubitril/valsartan) for heart failure, Cosentyx (secukinumab) for psoriasis, Kesimpta (ofatumumab) for multiple sclerosis, and Kisqali (ribociclib) for breast cancer.